Johan Askling

30.6k total citations · 4 hit papers
411 papers, 18.8k citations indexed

About

Johan Askling is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Johan Askling has authored 411 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Rheumatology, 93 papers in Pathology and Forensic Medicine and 70 papers in Genetics. Recurrent topics in Johan Askling's work include Rheumatoid Arthritis Research and Therapies (195 papers), Lymphoma Diagnosis and Treatment (72 papers) and Systemic Lupus Erythematosus Research (71 papers). Johan Askling is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (195 papers), Lymphoma Diagnosis and Treatment (72 papers) and Systemic Lupus Erythematosus Research (71 papers). Johan Askling collaborates with scholars based in Sweden, United States and Denmark. Johan Askling's co-authors include Lars Klareskog, Eva Baecklund, L. Jacobsson, Martin Neovius, Anders Ekbom, Anders Ekbom, Jonas F. Ludvigsson, Thomas Frisell, Nils Feltelius and Julia F. Simard and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Johan Askling

387 papers receiving 18.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

2006 667 citations Eva Baecklund, Johan Askling et al. profile →
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up

2009 604 citations Johan Askling et al. profile →
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study

2020 321 citations Ola Olén, Rune Erichsen et al. profile →
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden

2021 169 citations Jonas F. Ludvigsson, Johan Askling et al. profile →

Peers

Countries citing papers authored by Johan Askling

Since Specialization

Citations

This map shows the geographic impact of Johan Askling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Askling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Askling more than expected).

Fields of papers citing papers by Johan Askling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Askling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Askling. The network helps show where Johan Askling may publish in the future.

Co-authorship network of co-authors of Johan Askling

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Askling. A scholar is included among the top collaborators of Johan Askling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Askling. Johan Askling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maternal rheumatoid arthritis and the risk of offspring autism spectrum disorder: two national birth cohorts and a meta-analysis 2025 ·Molecular Autism ·Erpeng Zhu, Benjamin Hon Kei Yip, (unknown), (unknown), Arad Kodesh, Johan Askling, Abraham Reichenberg, Weiyao Yin, Stephen Z. Levine, Sven Sandin	0
2	Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis 2023 ·RMD Open ·(unknown), Johan Askling, Jon Lampa	0
3	Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study 2023 ·Annals of the Rheumatic Diseases ·Sofia Exarchou, Daniela Di Giuseppe, Eva Klingberg, Valgerður Sigurðardóttir, Sara Wedrén, Ulf Lindström, Carl Turesson, L. Jacobsson, Johan Askling, Johan K. Wallman	9
4	Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application 2023 ·Lara D. Veeken ·(unknown), Arvid Sjölander, Bénédicte Delcoigne, Johan Askling, Thomas Frisell	8
5	Disease‐modifying antirheumatic drugs and risk of thyroxine‐treated autoimmune thyroid disease in patients with rheumatoid arthritis 2023 ·Journal of Internal Medicine ·(unknown), Bénédicte Delcoigne, Saedís Saevarsdóttir, Johan Askling	5
6	The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017 2023 ·The Journal of Rheumatology ·Sofia Exarchou, Johan K. Wallman, Daniela Di Giuseppe, Eva Klingberg, Valgerður Sigurðardóttir, Sara Wedrén, Ulf Lindström, Carl Turesson, L. Jacobsson, Johan Askling	2
7	Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis 2023 ·Lara D. Veeken ·(unknown), Saedís Saevarsdóttir, Lina-Marcela Díaz-Gallo, (unknown), Lars Alfredsson, Lars Klareskog, Eva Baecklund, Lena Björkman, Alf Kastbom, Solbritt Rantapää‐Dahlqvist, Carl Turesson, Ingileif Jónsdóttir, Kāri Stefánsson, Thomas Frisell, Leonid Padyukov, Johan Askling, Helga Westerlind	1
8	Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA study 2022 ·Arthritis Research & Therapy ·(unknown), Anna Karin Hedström, Lars Klareskog, Daniela Di Giuseppe, Lars Alfredsson, Johan Askling, Sofia Ernestam, Saedís Saevarsdóttir, Lotta Ljung	0
9	Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study 2022 ·RMD Open ·René Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E. Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Björn Guðbjörnsson, Þorvarður Jón Löve, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren	2
10	Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration 2022 ·Lara D. Veeken ·Bénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, Daniela Di Giuseppe, Thomas Frisell, Bente Glintborg, Gerður Gröndal, Björn Guðbjörnsson, Merete Lund Hetland, Brigitte Michelsen, Dan Nordström, Heikki Relas, Johan Askling	4
11	Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register 2022 ·Scandinavian Journal of Rheumatology ·Johan K. Wallman, (unknown), Eva Klingberg, Valgerður Sigurðardóttir, Sara Wedrén, Sofia Exarchou, Ulf Lindström, Daniela Di Giuseppe, Johan Askling, L. Jacobsson	11
12	Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries 2022 ·Lara D. Veeken ·Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Sella Aarrestad Provan, Dan Nordström, (unknown), (unknown), Eirik Klami Kristianslund, Tore K Kvien, Björn Guðbjörnsson, Merete Lund Hetland, Brigitte Michelsen, L. Jacobsson, Johan Askling, Ulf Lindström	10
13	Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data 2021 ·Respirology ·Marios Rossides, Susanna Kullberg, Daniela Di Giuseppe, Anders Eklúnd, Johan Grünewald, Johan Askling, Elizabeth V. Arkema	24
14	Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs—a Swedish cohort study of risks by time, drug and lymphoma subtype 2020 ·Lara D. Veeken ·Karin Hellgren, Daniela Di Giuseppe, Karin E. Smedby, Christer Sundström, Johan Askling, Eva Baecklund, (unknown)	27
15	Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden 2020 ·Gut ·Jordan E. Axelrad, Ola Olén, Michael C. Sachs, Rune Erichsen, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Henrik Toft Sørensen, Jonas F. Ludvigsson	36
16	Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case–control study 2020 ·European Journal of Epidemiology ·Marios Rossides, Susanna Kullberg, Johan Askling, Anders Eklúnd, Johan Grünewald, Daniela Di Giuseppe, Elizabeth V. Arkema	12
17	Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study 2020 ·Lara D. Veeken ·Karin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, René Cordtz, Dan Nordström, Kalle Aaltonen, Björn Guðbjörnsson, Þorvarður Jón Löve, Sella Aarrestad Provan, Joe Sexton, Kristian Zobbe, Lars Erik Kristensen, Johan Askling, Lene Dreyer	9
18	Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study 2020 ·Lara D. Veeken ·(unknown), (unknown), Lene Dreyer, Merete Lund Hetland, Bente Glintborg, Johan Askling, Daniela Di Giuseppe, L. Jacobsson, Johan K. Wallman, Dan Nordström, Kalle Aaltonen, Eirik Klami Kristianslund, Tore K Kvien, Sella Aarrestad Provan, Björn Guðbjörnsson, Þorvarður Jón Löve, Lars Erik Kristensen	4
19	2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis 2019 ·Annals of the Rheumatic Diseases ·Lisa Ehlers, Johan Askling, (unknown), (unknown), Maurizio Cutolo, Bhaskar Dasgupta, Christian Dejaco, William G Dixon, Nils Feltelius, Axel Finckh, Kate Gilbert, Sarah Mackie, Alfred Mahr, Eric L. Matteson, Lorna Neill, Carlo Salvarani, Wolfgang Schmidt, Anja Strangfeld, Ronald van Vollenhoven, Frank Buttgereit	57
20	Familial aggregation and heritability of sarcoidosis: a Swedish nested case−control study 2018 ·European Respiratory Journal ·Marios Rossides, Johan Grünewald, Anders Eklúnd, Susanna Kullberg, Daniela Di Giuseppe, Johan Askling, Elizabeth V. Arkema	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact